Aspen Pharmacare plans to start supplying Johnson & Johnson Covid-19 vaccine doses from its facility in South Africa before the end of June, its chief executive said on Friday. Stephen Saad told Reuters in an interview that the technology transfer from J&J has "gone very well and we are now committing commercial supply in our financial year."
from Engineering News | Home https://ift.tt/3layEqa
